Literature DB >> 15464367

Protein-based tissue engineering in bone and cartilage repair.

John M Wozney1, Howard J Seeherman.   

Abstract

Bioactive proteins signal host or transplanted cells to form the desired tissue type. Matrix systems are utilized to locally deliver the proteins and to maintain effective protein concentrations. For some indications, a matrix is required to define the physical form of the regenerated tissue. Substantial progress has been made in bone tissue engineering in recent years, based on the results of controlled clinical studies using bone morphogenetic proteins. Ongoing research in this area centers on the design of additional delivery matrices to expand the clinical indications, using synthetic delivery systems that mimic biological qualities of the natural materials currently in use. Although a similar rationale exists for the regeneration of articular cartilage with bioactive factors, advancement in this area has not been as substantial.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464367     DOI: 10.1016/j.copbio.2004.08.001

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  15 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

Review 2.  Cell and gene therapy for bone repair.

Authors:  P J Marie
Journal:  Osteoporos Int       Date:  2011-06       Impact factor: 4.507

Review 3.  Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants.

Authors:  Juan Pablo Cattalini; Aldo R Boccaccini; Silvia Lucangioli; Viviana Mouriño
Journal:  Tissue Eng Part B Rev       Date:  2012-05-14       Impact factor: 6.389

4.  Engineered cell-free scaffold with two-stage delivery of miRNA-26a for bone repair.

Authors:  Joseph Paquet; Adrien Moya; Morad Bensidhoum; Hervé Petite
Journal:  Ann Transl Med       Date:  2016-05

Review 5.  Basic concepts regarding fracture healing and the current options and future directions in managing bone fractures.

Authors:  Amin Bigham-Sadegh; Ahmad Oryan
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

6.  Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis.

Authors:  Hidenori Matsubara; Daniel E Hogan; Elise F Morgan; Douglas P Mortlock; Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Bone       Date:  2012-02-25       Impact factor: 4.398

Review 7.  In vivo potency assay for the screening of bioactive molecules on cartilage formation.

Authors:  Anne-Sophie Thorup; Sara Caxaria; Bethan L Thomas; Yasir Suleman; Giovanna Nalesso; Frank P Luyten; Francesco Dell'Accio; Suzanne E Eldridge
Journal:  Lab Anim (NY)       Date:  2022-03-31       Impact factor: 9.667

8.  Experimental research on ectopic osteogenesis of BMP2-derived peptide P24 combined with PLGA copolymers.

Authors:  Zhixia Duan; Qixin Zheng; Xiaodong Guo; Quan Yuan; Shunguang Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

9.  Repair of rabbit femoral defects with a novel BMP2-derived oligopeptide P24.

Authors:  Zhixia Duan; Qixin Zheng; Xiaodong Guo; Changwen Li; Bin Wu; Weigang Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-08-15

10.  Injectable biocomposites for bone healing in rabbit femoral condyle defects.

Authors:  Jianheng Liu; Kezheng Mao; Zhengsheng Liu; Xiumei Wang; Fuzhai Cui; Wenguang Guo; Keya Mao; Shuying Yang
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.